Genetics of neuropathies

Seminars in Neurology

Volumn 31, Issue 5, 2011, Pages 494-505

  Siskind, Carly E ^a   Shy, Michael E ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Charcot Marie Tooth disease; genetic testing; inherited; Peripheral neuropathy

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; GENE LOCUS; GENETIC SCREENING; HEREDITARY MOTOR SENSORY NEUROPATHY; HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSY; HUMAN; NEUROPATHY; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; ULCER; WASTING SYNDROME; WEAKNESS;

CHARCOT-MARIE-TOOTH DISEASE; GENETIC HETEROGENEITY; GENETIC TESTING; HEREDITARY SENSORY AND MOTOR NEUROPATHY; HUMANS; MUTATION;

EID: 84856133912     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0031-1299788     Document Type: Article

References (95)

1. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 1974 6 2 98-118
2. Harding A E., Thomas P K. Genetic aspects of hereditary motor and sensory neuropathy (types I and II). J Med Genet 1980 17 5 329-336 (Pubitemid 10018613)
3. Harding A E., Thomas P K. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980 103 2 259-280 (Pubitemid 10046623)
4. Thomas P K., Harding A E. Inherited neuropathies: the interface between molecular genetics and pathology. Brain Pathol 1993 3 2 129-133 (Pubitemid 23139414)
5. Michels V V., Dyck P J. Mendelian inheritance and basis of classification of hereditary neuropathy with neuronal atrophy and degeneration. In: Dyck P, Thomas P K., Lambert E H., Bunge R, eds. Peripheral Neuropathy. 2nd ed. Philadelphia WB Saunders 1984 1512-1524
6. Dubourg O, Tardieu S, Birouk N et al. The frequency of 17p11.2 duplication and Connexin 32 mutations in 282 Charcot-Marie-Tooth families in relation to the mode of inheritance and motor nerve conduction velocity. Neuromuscul Disord 2001 11 5 458-463 (Pubitemid 32510005)
7. England J D., Gronseth G S., Franklin G et al, American Academy of Neurology American Association of Neuromuscular and Electrodiagnostic Medicine American Academy of Physical Medicine and Rehabilitation. Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. PM R 2009 1 1 5-13
8. England J D., Gronseth G S., Franklin G et al, American Academy of Neurology. Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009 72 2 185-192
9. Burgunder J M., Schöls L, Baets J et al, EFNS. EFNS guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders. Eur J Neurol 2011 18 2 207-217
10. Saporta A S., Sottile S L., Miller L J., Feely S M., Siskind C E., Shy M E. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011 69 1 22-33
11. Feely S M., Laura M, Siskind C E. et al. MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology 2011 76 20 1690-1696
12. Krajewski K M., Shy M E. Genetic testing in neuromuscular disease. Neurol Clin 2004 22 3 481-508, v v (Pubitemid 38797979)
13. Shy M E., Chen L, Swan E R. et al. Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology 2008 70 5 378-383 (Pubitemid 351653401)
14. Shy M E., Siskind C, Swan E R. et al. CMT1X phenotypes represent loss of GJB1 gene function. Neurology 2007 68 11 849-855 (Pubitemid 46568537)
15. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. Am J Hum Genet 1995 57 5 1233-1241
16. Lewis R A., Sumner A J., Shy M E. Electrophysiological features of inherited demyelinating neuropathies: A reappraisal in the era of molecular diagnosis. Muscle Nerve 2000 23 10 1472-1487
17. Kamholz J, Menichella D, Jani A et al. Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy. Brain 2000 123 Pt 2 222-233 (Pubitemid 30055147)
18. Lupski J R., de Oca-Luna R M., Slaugenhaupt S et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991 66 2 219-232 (Pubitemid 121001361)
19. Raeymaekers P, Timmerman V, Nelis E et al, The HMSN Collaborative Research Group. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). Neuromuscul Disord 1991 1 2 93-97
20. Sheth S, Francies K, Siskind C E., Feely S M., Lewis R A., Shy M E. Diabetes mellitus exacerbates motor and sensory impairment in CMT1A. J Peripher Nerv Syst 2008 13 4 299-304
21. Blair I P., Nash J, Gordon M J., Nicholson G A. Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: first report of a de novo duplication with a maternal origin. Am J Hum Genet 1996 58 3 472-476 (Pubitemid 26062477)
22. Passage E, Norreel J C., Noack-Fraissignes P et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med 2004 10 4 396-401 (Pubitemid 38508518)
23. Verhamme C, de Haan R J., Vermeulen M, Baas F, de Visser M, van Schaik I N. Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial. BMC Med 2009 7 70
24. Burns J, Ouvrier R A., Yiu E M. et al. Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial. Lancet Neurol 2009 8 6 537-544
25. Micallef J, Attarian S, Dubourg O et al. Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2009 8 12 1103-1110
26. Pareyson D, Reilly M M., Schenone A et al, CMT-TRIAAL CMT-TRAUK groups. Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol 2011 10 4 320-328
27. Chance P F., Alderson M K., Leppig K A. et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993 72 1 143-151 (Pubitemid 23029701)
28. Infante J, García A, Combarros O et al. Diagnostic strategy for familial and sporadic cases of neuropathy associated with 17p11.2 deletion. Muscle Nerve 2001 24 9 1149-1155 (Pubitemid 32762142)
29. Stögbauer F, Young P, Kuhlenbäumer G, De Jonghe P, Timmerman V. Hereditary recurrent focal neuropathies: clinical and molecular features. Neurology 2000 54 3 546-551 (Pubitemid 30082916)
30. Andersson P B., Yuen E, Parko K, So Y T. Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. Neurology 2000 54 1 40-44 (Pubitemid 30038735)
31. Li J, Krajewski K, Shy M E., Lewis R A. Hereditary neuropathy with liability to pressure palsy: the electrophysiology fits the name. Neurology 2002 58 12 1769-1773 (Pubitemid 34663576)
32. Hayasaka K, Himoro M, Sato W et al. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet 1993 5 1 31-34 (Pubitemid 23261514)
33. Street V A., Bennett C L., Goldy J D. et al. Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 2003 60 1 22-26 (Pubitemid 36070638)
34. Latour P, Gonnaud P M., Ollagnon E et al. SIMPLE mutation analysis in dominant demyelinating Charcot-Marie-Tooth disease: three novel mutations. J Peripher Nerv Syst 2006 11 2 148-155 (Pubitemid 43894082)
35. Saifi G M., Szigeti K, Wiszniewski W et al. SIMPLE mutations in Charcot-Marie-Tooth disease and the potential role of its protein product in protein degradation. Hum Mutat 2005 25 4 372-383 (Pubitemid 40524665)
36. Warner L E., Mancias P, Butler I J. et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998 18 4 382-384 (Pubitemid 28158170)
37. Vandenberghe N, Upadhyaya M, Gatignol A et al. Frequency of mutations in the early growth response 2 gene associated with peripheral demyelinating neuropathies. J Med Genet 2002 39 12 e81
38. Pareyson D, Taroni F, Botti S et al. Cranial nerve involvement in CMT disease type 1 due to early growth response 2 gene mutation. Neurology 2000 54 8 1696-1698 (Pubitemid 30226822)
39. Boerkoel C F., Takashima H, Garcia C A. et al. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 2002 51 2 190-201 (Pubitemid 34111441)
40. Russo M, Laur M, Polke J M. et al. Variable phenotypes are associated with PMP22 missense mutations. Neuromuscul Disord 2011 21 2 106-114
41. Zchner S, Mersiyanova I V., Muglia M et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004 36 5 449-451 (Pubitemid 38620027)
42. Verhoeven K, De Jonghe P, Coen K et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 2003 72 3 722-727 (Pubitemid 36255971)
43. Auer-Grumbach M, De Jonghe P, Wagner K, Verhoeven K, Hartung H P., Timmerman V. Phenotype-genotype correlations in a CMT2B family with refined 3q13-q22 locus. Neurology 2000 55 10 1552-1557
44. De Jonghe P, Timmerman V, FitzPatrick D, Spoelders P, Martin J J., Van Broeckhoven C. Mutilating neuropathic ulcerations in a chromosome 3q13-q22 linked Charcot-Marie-Tooth disease type 2B family. J Neurol Neurosurg Psychiatry 1997 62 6 570-573 (Pubitemid 27281257)
45. Kwon J M., Elliott J L., Yee W C. et al. Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q. Am J Hum Genet 1995 57 4 853-858
46. Landouré G, Zdebik A A., Martinez T L. et al. Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet 2010 42 2 170-174
47. Chen D H., Sul Y, Weiss M et al. CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene. Neurology 2010 75 22 1968-1975
48. Deng H X., Klein C J., Yan J et al. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. Nat Genet 2010 42 2 165-169
49. Dyck P J., Litchy W J., Minnerath S et al. Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. Ann Neurol 1994 35 5 608-615 (Pubitemid 24153845)
50. Klein C J., Cunningham J M., Atkinson E J. et al. The gene for HMSN2C maps to 12q23-24: a region of neuromuscular disorders. Neurology 2003 60 7 1151-1156 (Pubitemid 36418777)
51. Antonellis A, Ellsworth R E., Sambuughin N et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 2003 72 5 1293-1299 (Pubitemid 36530017)
52. Sivakumar K, Kyriakides T, Puls I et al. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain 2005 128 Pt 10 2304-2314 (Pubitemid 41407971)
53. Mersiyanova I V., Perepelov A V., Polyakov A V. et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 2000 67 1 37-46 (Pubitemid 30481542)
54. Georgiou D M., Zidar J, Korosec M, Middleton L T., Kyriakides T, Christodoulou K. A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family. Neurogenetics 2002 4 2 93-96 (Pubitemid 36019504)
55. Yoshihara T, Yamamoto M, Hattori N et al. Identification of novel sequence variants in the neurofilament-light gene in a Japanese population: analysis of Charcot-Marie-Tooth disease patients and normal individuals. J Peripher Nerv Syst 2002 7 4 221-224 (Pubitemid 35439787)
56. Jordanova A, De Jonghe P, Boerkoel C F. et al. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 2003 126 Pt 3 590-597 (Pubitemid 36240860)
57. Perez-Olle R, Leung C L., Liem R K. Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation. J Cell Sci 2002 115 Pt 24 4937-4946 (Pubitemid 36054645)
58. Evgrafov O V., Mersiyanova I, Irobi J et al. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 2004 36 6 602-606 (Pubitemid 38715987)
59. Chung K W., Kim S B., Cho S Y. et al. Distal hereditary motor neuropathy in Korean patients with a small heat shock protein 27 mutation. Exp Mol Med 2008 40 3 304-312
60. Houlden H, Laura M, Wavrant-De Vrize F et al. Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2. Neurology 2008 71 21 1660-1668
61. Solla P, Vannelli A, Bolino A et al. Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy. J Neurol Neurosurg Psychiatry 2010 81 9 958-962
62. Tang B S., Zhao G H., Luo W et al. Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum Genet 2005 116 3 222-224 (Pubitemid 40174008)
63. Irobi J, Van Impe K, Seeman P et al. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet 2004 36 6 597-601 (Pubitemid 38715986)
64. Tang B S., Luo W, Xia K et al. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2L) maps to chromosome 12q24. Hum Genet 2004 114 6 527-533 (Pubitemid 39010849)
65. Baxter R V., Ben Othmane K, Rochelle J M. et al. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat Genet 2002 30 1 21-22
66. Sivera R, Espins C, Vílchez J J. et al. Phenotypical features of the p.R120W mutation in the GDAP1 gene causing autosomal dominant Charcot-Marie-Tooth disease. J Peripher Nerv Syst 2010 15 4 334-344
67. Claramunt R, Pedrola L, Sevilla T et al. Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect. J Med Genet 2005 42 4 358-365 (Pubitemid 40523959)
68. Crimella C, Tonelli A, Airoldi G et al. The GST domain of GDAP1 is a frequent target of mutations in the dominant form of axonal Charcot Marie Tooth type 2K. J Med Genet 2010 47 10 712-716
69. Senderek J, Bergmann C, Ramaekers V T. et al. Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy. Brain 2003 126 Pt 3 642-649 (Pubitemid 36240865)
70. Nelis E, Erdem S, Van Den Bergh P Y. et al. Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy. Neurology 2002 59 12 1865-1872 (Pubitemid 36076556)
71. Sevilla T, Cuesta A, Chumillas M J. et al. Clinical, electrophysiological and morphological findings of Charcot-Marie-Tooth neuropathy with vocal cord palsy and mutations in the GDAP1 gene. Brain 2003 126 Pt 9 2023-2033 (Pubitemid 37059442)
72. Boerkoel C F., Takashima H, Nakagawa M et al. CMT4A: identification of a Hispanic GDAP1 founder mutation. Ann Neurol 2003 53 3 400-405 (Pubitemid 36258646)
73. Bolino A, Muglia M, Conforti F L. et al. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 2000 25 1 17-19 (Pubitemid 30257029)
74. Houlden H, King R H., Wood N W., Thomas P K., Reilly M M. Mutations in the 5 region of the myotubularin-related protein 2 (MTMR2) gene in autosomal recessive hereditary neuropathy with focally folded myelin. Brain 2001 124 Pt 5 907-915 (Pubitemid 32458503)
75. Parman Y, Battaloglu E, Baris I et al. Clinicopathological and genetic study of early-onset demyelinating neuropathy. Brain 2004 127 Pt 11 2540-2550 (Pubitemid 39472982)
76. Tyson J, Ellis D, Fairbrother U et al. Hereditary demyelinating neuropathy of infancy. A genetically complex syndrome. Brain 1997 120 Pt 1 47-63 (Pubitemid 27081260)
77. Verny C, Ravisé N, Leutenegger A L. et al. Coincidence of two genetic forms of Charcot-Marie-Tooth disease in a single family. Neurology 2004 63 8 1527-1529 (Pubitemid 39426299)
78. Senderek J, Bergmann C, Weber S et al. Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum Mol Genet 2003 12 3 349-356 (Pubitemid 36204431)
79. Azzedine H, Bolino A, Taeb T et al. Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am J Hum Genet 2003 72 5 1141-1153 (Pubitemid 36530002)
80. Senderek J, Bergmann C, Stendel C et al. Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy. Am J Hum Genet 2003 73 5 1106-1119 (Pubitemid 37414223)
81. Gooding R, Colomer J, King R et al. A novel gypsy founder mutation, p.Arg1109X in the CMT4C gene, causes variable peripheral neuropathy phenotypes. J Med Genet 2005 42 12 e69
82. Colomer J, Gooding R, Angelicheva D et al. Clinical spectrum of CMT4C disease in patients homozygous for the p.Arg1109X mutation in SH3TC2. Neuromuscul Disord 2006 16 7 449-453 (Pubitemid 44094101)
83. Azzedine H, Ravisé N, Verny C et al. Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations. Neurology 2006 67 4 602-606 (Pubitemid 44321436)
84. Lauthov P, Mazanec R, Vondrek P et al. High frequency of SH3TC2 mutations in Czech HMSN I patients. Clin Genet 2011 80 334-345
85. Houlden H, Laura M, Ginsberg L et al. The phenotype of Charcot-Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy. Neuromuscul Disord 2009 19 4 264-269
86. Boerkoel C F., Takashima H, Stankiewicz P et al. Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am J Hum Genet 2001 68 2 325-333 (Pubitemid 32147803)
87. Guilbot A, Williams A, Ravisé N et al. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet 2001 10 4 415-421 (Pubitemid 32166552)
88. Marchesi C, Milani M, Morbin M et al. Four novel cases of periaxin-related neuropathy and review of the literature. Neurology 2010 75 20 1830-1838
89. Kabzinska D, Drac H, Sherman D L. et al. Charcot-Marie-Tooth type 4F disease caused by S399fsx410 mutation in the PRX gene. Neurology 2006 66 5 745-747 (Pubitemid 43739835)
90. Chow C Y., Zhang Y, Dowling J J. et al. Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature 2007 448 7149 68-72 (Pubitemid 47036999)
91. Zhang X, Chow C Y., Sahenk Z, Shy M E., Meisler M H., Li J. Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration. Brain 2008 131 Pt 8 1990-2001
92. Bergoffen J, Scherer S S., Wang S et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993 262 5142 2039-2042 (Pubitemid 24041884)
93. Siskind C E., Murphy S M., Ovens R, Polke J, Reilly M M., Shy M E. Phenotype expression in women with CMT1X. J Peripher Nerv Syst 2011 16 2 102-107
94. Siskind C, Feely S M., Bernes S, Shy M E., Garbern J Y. Persistent CNS dysfunction in a boy with CMT1X. J Neurol Sci 2009 279 1-2 109-113
95. Reilly M M., Shy M E. Diagnosis and new treatments in genetic neuropathies. JNNP 2009 80 12 1304-1314